Andorra vs North Macedonia: The number of people with susceptibility test result for rifampicin
Andorra
100
in 2021
North Macedonia
100
in 2021
Andorra rank
2nd
North Macedonia rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Andorra
- North Macedonia
How they compare
Andorra currently reports 100 against 100 in North Macedonia, a difference of 0.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was North Macedonia ahead.
Andorra ranks 2nd and North Macedonia ranks 2nd of 146 countries.
Across the 2 decades both report, Andorra averaged higher in 1 and North Macedonia in 1.
Head to head by decade
| Decade | Andorra | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.67 | 98.27 | 31.6 | North Macedonia |
| 2020s | 100 | 92.63 | 7.37 | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Andorra or North Macedonia?
- Andorra, at 100 against 100 in North Macedonia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Andorra and North Macedonia?
- 0, with Andorra ahead.
- How many years of comparable data are there for Andorra and North Macedonia?
- 5 years are reported by both, from 2017 to 2021.
- How do Andorra and North Macedonia rank globally for the number of people with susceptibility test result for rifampicin?
- Andorra ranks 2nd and North Macedonia ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.